SLONIN JONATHAN 4
4 · Pacira BioSciences, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Award
Common Stock
2025-02-01+93,600→ 187,043.511 total
Footnotes (1)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.